This study enrolled 30 menopaused patientswith OAB symptoms from november 2022 to november 2023. the mean age was 51 yo, varing from 37 to 88 yo.
The inclusion criteria was symptoms of OAB syndrome refractary to anti muscarinics and with no stress urinary incontinence associated.
Exclusion criteria were clinically significant bladder outflow obstruction, significant post-void residual PVR < 200 ml, associated SUI ,diabetic neuropathy, UTI, active genital infections, previous pelvic radiation therapy, current malignant diseases and pelvic organ prolapse POP stage > ll HWS classification and or the use of HRT (systemic or local) up to 6 months before the study recruiment period.
GSU symptoms was also evaluated at T0 and T1 (vaginal itching, vaginal burning, vaginal dryness and dyspareunia) using a visual analog scale (VAS), which is based on a score from 1 to 10, where 1 indicates the absense of symptoms .
At T0 and T1, eligible patients adduced a micturition diary, which was to be completed during the 3 days preceding the visit.In the diary , patients were asked in specify the number of micturitions,number of urgency episodes and number of incontinence episodes,for every considered day.
Overactive bladder symptoms were assessed using the validated Overactive Bladder Quetionnarie Short Form (OAB-Q SF).
Eventual adverse events which occurred or were referred by the patients were recorded. We considered any disorder, disconfort local and general, arising in relation to the non ablative RF as an adverse event. All patients underwent 5 sessions of 15 minutes once a week for 5 weeks of capacitive radiofrquency intravaginally. C-500 Capenergy device was used. No local anesthetic was necessary. Statistical analysis was performed with SPSS for Windows (version 17.0, SPSS Inc., Chicago, IL, USA). Data were presented as median /IQR. Differences between VAS at T= and T1 were analyzed with Wilcoxon test. Statistical significance was set at p<0.05.Statistical analysis was performed with SPSS for Windows (version 17.0, SPSS Inc., Chicago, IL, USA). Data were presented as median /IQR. Differences between VAS at T= and T1 were analyzed with Wilcoxon test. Statistical significance was set at p<0.05.
Statistical analysis was performed with SPSS for Windows (version 17.0, SPSS Inc., Chicago, IL, USA). Data were presented as median /IQR. Differences between VAS at T= and T1 were analyzed with Wilcoxon test. Statistical significance was set at p<0.05.